Personalis (NASDAQ:PSNL) CFO Aaron Tachibana Sells 4,982 Shares of Stock

Personalis, Inc. (NASDAQ:PSNL) CFO Aaron Tachibana sold 4,982 shares of the business’s stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $14.00, for a total value of $69,748.00. Following the sale, the chief financial officer directly owned 198,833 shares of the company’s stock, valued at $2,783,662. This represents a 2.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Aaron Tachibana also recently made the following trade(s):

• On Friday, June 26th, Aaron Tachibana sold 51,251 shares of Personalis stock. The stock was sold at an average price of $13.18, for a total value of $675,488.18.
• On Thursday, June 4th, Aaron Tachibana sold 40,000 shares of Personalis stock. The shares were sold at an average price of $12.01, for a total value of $480,400.00.
• On Friday, May 29th, Aaron Tachibana sold 38,799 shares of Personalis stock. The shares were sold at an average price of $11.58, for a total value of $449,292.42.

Personalis Stock Up 5.6%

Shares of NASDAQ:PSNL opened at $13.75 on Tuesday. The business’s 50 day moving average is $8.56 and its 200 day moving average is $8.31. Personalis, Inc. has a 12-month low of $3.84 and a 12-month high of $14.07. The stock has a market cap of $1.44 billion, a price-to-earnings ratio of -13.48 and a beta of 2.27.

Personalis (NASDAQ:PSNL) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.06). The company had revenue of $15.47 million during the quarter, compared to analysts’ expectations of $14.48 million. Personalis had a negative net margin of 148.11% and a negative return on equity of 43.52%. As a group, equities research analysts expect that Personalis, Inc. will post -1.06 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on PSNL shares. BTIG Research cut their price target on shares of Personalis from $13.00 to $11.00 and set a “buy” rating on the stock in a report on Monday, May 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Personalis in a research note on Tuesday, April 21st. Wall Street Zen cut shares of Personalis from a “hold” rating to a “sell” rating in a research report on Saturday, June 13th. Finally, Morgan Stanley cut their target price on Personalis from $10.00 to $9.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $11.00.

Hedge Funds Weigh In On Personalis

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd increased its holdings in Personalis by 76.1% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,423 shares of the company’s stock worth $27,000 after acquiring an additional 1,479 shares during the last quarter. Deutsche Bank AG lifted its holdings in Personalis by 4.5% during the fourth quarter. Deutsche Bank AG now owns 38,827 shares of the company’s stock valued at $309,000 after purchasing an additional 1,655 shares during the last quarter. Royal Bank of Canada lifted its holdings in Personalis by 3.2% during the first quarter. Royal Bank of Canada now owns 78,341 shares of the company’s stock valued at $275,000 after purchasing an additional 2,395 shares during the last quarter. Howland Capital Management LLC boosted its position in Personalis by 0.9% during the second quarter. Howland Capital Management LLC now owns 285,308 shares of the company’s stock worth $1,872,000 after purchasing an additional 2,500 shares during the period. Finally, Intech Investment Management LLC boosted its position in Personalis by 23.4% during the fourth quarter. Intech Investment Management LLC now owns 20,342 shares of the company’s stock worth $162,000 after purchasing an additional 3,851 shares during the period. 61.91% of the stock is owned by hedge funds and other institutional investors.

About Personalis

Personalis, Inc (NASDAQ: PSNL) is a clinical‐stage genomics company that develops and markets advanced next‐generation sequencing (NGS) services and assays designed to accelerate precision medicine. The Company’s core offering is the ImmunoID NeXT™ Platform, which combines comprehensive tumor profiling—including whole exome, transcriptome, and T‐cell receptor sequencing—with proprietary bioinformatics to identify biomarkers and guide immuno‐oncology research. Personalis serves biopharmaceutical companies, academic institutions, and clinical research organizations seeking in‐depth insights into cancer, autoimmune diseases and other complex conditions.

In addition to its flagship ImmunoID NeXT™ Platform, Personalis offers a suite of customizable sequencing assays for biomarker discovery, clinical trial support and companion diagnostic development.